- 专利标题： 2-pyrimidinyl pyrazolopyridine ErbB kinase inhibitors
-
申请号： US11721504申请日： 2005-12-06
-
公开(公告)号： US07812022B2公开(公告)日： 2010-10-12
- 发明人: David Edward Uehling , Kirk Lawrence Stevens , Scott Howard Dickerson , Alex Gregory Waterson , Philip Anthony Harris , Douglas McCord Sammond , Robert Dale Hubbard , Holly Kathleen Emerson , Joseph W. Wilson
- 申请人： David Edward Uehling , Kirk Lawrence Stevens , Scott Howard Dickerson , Alex Gregory Waterson , Philip Anthony Harris , Douglas McCord Sammond , Robert Dale Hubbard , Holly Kathleen Emerson , Joseph W. Wilson
- 申请人地址： US PA Philadelphia
- 专利权人： GlaxoSmithKline LLC
- 当前专利权人： GlaxoSmithKline LLC
- 当前专利权人地址： US PA Philadelphia
- 代理商 J. Scott Young
- 国际申请： PCT/US2005/044166 WO 20051206
- 国际公布： WO2006/068826 WO 20060629
- 主分类号： C07D471/04
- IPC分类号： C07D471/04 ; A61K31/437
摘要：
The present invention provides 2-pyrimidinyl pyrazolopyridine compounds, compositions containing the same, as well as processes for the preparation and their use as pharmaceutical agents.
公开/授权文献
- US20080051395A1 2-Pyrimidinyl Pyrazolopyridine Erbb Kinase Inhibitors 公开/授权日：2008-02-28